Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Applied DNA Sciences Inc APDN

Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.


NDAQ:APDN - Post by User

User Avatar Image
(7)
•••
  • turner20001X
Post by turner20001on Mar 04, 2024 2:55pm
59 Views
Post# 35913971

Linear DNA STINKS!

Linear DNA STINKS!STRONG SELL RECOMMENDATION - 600 Reasons to Sell this Dumpster Stock
241. It is imperative that you understand one important thing. APDN is an experimental company.
242. The research APDN is currently doing is completely experimental. Clinical tests have not been performed! Proof of concept for successful commercialization has not been completed. The risks with APDN are enormous. Do not underestimate the extreme risks with APDN!!
243.  It will take many years to commercialize any potential product. And that’s a big if!
244. Unfortunately, CEO Hayward refuses to disclose these critical facts.
245. There’s a huge technology war going on today involving DNA and RNA replication.
246. How can APDN compete against multibillion dollar companies like Moderna?
247. Moderna employs hundreds of the best scientists in the world. That’s a fact!
248. Moderna spends billions of dollars on R & D. That’s a fact!
249. On the other hand, APDN spends most of its money on insider compensation, leaving very little for R & D. That’s a fact!
250. I just can’t imagine how APDN can ever be successful. It’s nearly impossible! That’s a fact!
 
STRONG SELL RECOMMENDATION - 600 Reasons to Sell this Dumpster Stock
251. I know someone who works in Venture Capital and asked him about APDN. He told me that his company does its due diligence to an extreme.
252. He looked at APDN and told me no VC firm will touch this company. It has many problems.
253. It's always short on funding. Reverse stock splits are often a death knell for a company. And the company simply is not focused.
254. He told me a story about vitamin water. He said a sports player paid $1 million in seed money and a few years later Coke bought him out for $100 million. VC firms work in much the same way.
255. He explained that the company making vitamin water was extremely focused. They did one thing and they did it very well.
256. Also, it was very simple and everyone knows about vitamins and water. So there are no surprises here.
257. On the other hand, APDN is not focused on any one product. The products they are working on are all new technologies without a long-track record and you can bet there will be some surprises and setbacks.
258. He also said that investing in this company carries way too much risk.
259. It should have been a private company, but the insiders wanted to take APDN public so they could make more money and could more easily liquidate their holdings.
260. He also added, "Don't even try to trade this stock, it is way too dangerous!"

<< Previous
Bullboard Posts
Next >>